Jeffrey Scholten - Schnute, M. E.*; O'Brien, P.M.; Nahra, J.; Morris, M.; Roark, W.H.; Hanau, C.E.; Ruminski, P.G.; Scholten, J.A.; Fletcher, T.R.; Hamper, B.C.; Carroll, J

Document created by Jeffrey Scholten on Aug 22, 2014
Version 1Show Document
  • View in full screen mode

  Publication Details (including relevant citation   information): Schnute, M. E.*; O'Brien, P.M.; Nahra, J.;   Morris, M.; Roark, W.H.; Hanau, C.E.; Ruminski, P.G.; Scholten,   J.A.; Fletcher, T.R.; Hamper, B.C.; Carroll, J.N.; Patt, W.C.;   Shieh, H.S.; Collins, B.; Pavlovsky, A. G.; Palmquist, K. E.;   Aston, K.W.; Hitchcock, J.; Rogers, M.D.; McDonald, J.; Johnson,   A.R.; Munie, G.E.; Man, C.F.; Settle, S.L.; Nemirovskiy, O.;   Vickery, L.E.; Agawal, A.; Dyer, R.D.; Sunyer, T. Discovery of   (Pyridin-4-yl)-2H-tetrazole as a Novel Scaffold to Identify   Highly Selective Matrix Metalloproteinase-13 Inhibitors for the   Treatment of Osteoarthritis. Bioorg. Med. Chem. Lett., 2009

  Abstract: null

  Address (URL):

 

Attachments

    Outcomes